Karyopharm Therapeutics Inc.
KPTI
$8.38
-$0.17-1.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -208.50% | 11.07% | -58.78% | 23.78% | 4.03% |
| Total Depreciation and Amortization | -84.30% | 55.13% | 0.00% | -3.70% | -2.41% |
| Total Amortization of Deferred Charges | -12.93% | 3.24% | 5.71% | 9.16% | -2.08% |
| Total Other Non-Cash Items | 716.63% | 76.82% | 134.28% | -142.12% | -1,864.57% |
| Change in Net Operating Assets | -61.40% | 41.76% | 759.02% | -116.21% | -10.22% |
| Cash from Operations | -101.84% | 68.66% | 52.04% | -51.04% | -32.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.06% | -73.72% | 19.60% | 3.69% | 97.27% |
| Cash from Investing | 4.06% | -73.72% | 19.60% | 3.32% | 97.98% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 150.00% | -75.00% | 60.00% | 125.00% | -155.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,271.79% | -2,093.75% | 99.80% | -128.83% | 13.31% |